Measles and rubella vaccine “Mabella” launched by Vaccine maker Indian Immunologicals (IIL) for children

Measles and rubella vaccine “Mabella” launched by Vaccine maker Indian Immunologicals (IIL) for children.
This live-attenuated MR vaccine has been developed in an exclusive partnership with the Polyvac Institute of Vietnam.
Mabella was launched as part of the 25th celebrations of the IIL division Human Biologicals Institute (HBI) in Udhagamandalam (Ooty), Tamil Nadu.
The vaccine has been proven to be safe and effective through extensive human clinical trials.
It will addresses the urgent need to control the deadly measles and rubella that kill nearly a million children globally.
In 1998, the Human Biological Institute (HBI), a division of IIL, was established at a time when the need for indigenous vaccines was paramount.
It developed India’s first safe vero-cell rabies vaccine – Abhayrab in 1998, which paved the way for phasing out painful nerve tissue vaccines.